2,469 reports of this reaction
5.0% of all CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE reports
#1 most reported adverse reaction
DRUG HYPERSENSITIVITY is the #1 most commonly reported adverse reaction for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, manufactured by Sandoz Inc. There are 2,469 FDA adverse event reports linking CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE to DRUG HYPERSENSITIVITY. This represents approximately 5.0% of all 49,809 adverse event reports for this drug.
Patients taking CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE who experience drug hypersensitivity should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG HYPERSENSITIVITY is moderately reported among CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE users, representing a notable but not dominant share of adverse events.
In addition to drug hypersensitivity, the following adverse reactions have been reported for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE:
The following drugs have also been linked to drug hypersensitivity in FDA adverse event reports:
DRUG HYPERSENSITIVITY has been reported as an adverse event in 2,469 FDA reports for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG HYPERSENSITIVITY accounts for approximately 5.0% of all adverse event reports for CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, making it one of the most commonly reported side effect.
If you experience drug hypersensitivity while taking CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.